A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
Identifieur interne : 001593 ( Main/Exploration ); précédent : 001592; suivant : 001594A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
Auteurs : Yuki Ishikawa [Japon] ; Naoichiro Yukawa [Japon] ; Daisuke Kawabata [Japon] ; Koichiro Ohmura [Japon] ; Takao Fujii [Japon] ; Takashi Usui [Japon] ; Tsuneyo Mimori [Japon]Source :
- Clinical Rheumatology [ 0770-3198 ] ; 2011-03-01.
English descriptors
Abstract
Abstract: In our earlier study, we had reported the case of a patient with rheumatoid arthritis (RA), who had anti-Jo-1 antibodies. This patient had received etanercept (ETN) therapy for RA, after which she had developed overt polymyositis (PM). Although various autoimmune phenomena, including lupus-like diseases, vasculitides, or psoriatic skin lesions, are associated with antitumor necrosis factor (TNF) therapy, the development of PM/dermatomyositis (DM) or antisynthetase syndrome following anti-TNF therapy is extremely rare. Here, we report a case of an RA patient with anti-PL-12 antibodies, who received ETN therapy and subsequently developed the antisynthetase syndrome. She recovered when ETN therapy was withdrawn and high-dose corticosteroid was administered. To date, there have been only five reported cases of RA patients with anti-Jo-1 antibodies who developed overt PM/DM following anti-TNF therapy and only one case of antisynthetase syndrome in an RA patient with anti-PL-7 antibodies. Our patients and the abovementioned reports strongly suggest that onset of overt PM/DM or antisynthetase syndrome in RA patients with anti-aminoacyl tRNA synthetase antibodies is associated with anti-TNF therapy.
Url:
DOI: 10.1007/s10067-010-1666-1
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001E92
- to stream Istex, to step Curation: 001E92
- to stream Istex, to step Checkpoint: 000569
- to stream Main, to step Merge: 001595
- to stream Main, to step Curation: 001593
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept</title><author><name sortKey="Ishikawa, Yuki" sort="Ishikawa, Yuki" uniqKey="Ishikawa Y" first="Yuki" last="Ishikawa">Yuki Ishikawa</name></author><author><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name></author><author><name sortKey="Kawabata, Daisuke" sort="Kawabata, Daisuke" uniqKey="Kawabata D" first="Daisuke" last="Kawabata">Daisuke Kawabata</name></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name></author><author><name sortKey="Usui, Takashi" sort="Usui, Takashi" uniqKey="Usui T" first="Takashi" last="Usui">Takashi Usui</name></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5A9AABB4733C827458F8010779A757CB34A27F0F</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s10067-010-1666-1</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-G2NDKC4R-R/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001E92</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001E92</idno><idno type="wicri:Area/Istex/Curation">001E92</idno><idno type="wicri:Area/Istex/Checkpoint">000569</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000569</idno><idno type="wicri:doubleKey">0770-3198:2011:Ishikawa Y:a:case:of</idno><idno type="wicri:Area/Main/Merge">001595</idno><idno type="wicri:Area/Main/Curation">001593</idno><idno type="wicri:Area/Main/Exploration">001593</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept</title><author><name sortKey="Ishikawa, Yuki" sort="Ishikawa, Yuki" uniqKey="Ishikawa Y" first="Yuki" last="Ishikawa">Yuki Ishikawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Japon</country></affiliation></author><author><name sortKey="Kawabata, Daisuke" sort="Kawabata, Daisuke" uniqKey="Kawabata D" first="Daisuke" last="Kawabata">Daisuke Kawabata</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Usui, Takashi" sort="Usui, Takashi" uniqKey="Usui T" first="Takashi" last="Usui">Takashi Usui</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author><author><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Rheumatology and Clinical Immunology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, 606-8507, Kyoto</wicri:regionArea><wicri:noRegion>Kyoto</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Rheumatology</title><title level="j" type="sub">Journal of the International League of Associations for Rheumatology</title><title level="j" type="abbrev">Clin Rheumatol</title><idno type="ISSN">0770-3198</idno><idno type="eISSN">1434-9949</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>London</pubPlace><date type="published" when="2011-03-01">2011-03-01</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="429">429</biblScope><biblScope unit="page" to="432">432</biblScope></imprint><idno type="ISSN">0770-3198</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0770-3198</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adverse drug effect</term><term>Anti-ARS antibodies</term><term>Anti-TNF therapy</term><term>Polymyositis/dermatomyositis</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: In our earlier study, we had reported the case of a patient with rheumatoid arthritis (RA), who had anti-Jo-1 antibodies. This patient had received etanercept (ETN) therapy for RA, after which she had developed overt polymyositis (PM). Although various autoimmune phenomena, including lupus-like diseases, vasculitides, or psoriatic skin lesions, are associated with antitumor necrosis factor (TNF) therapy, the development of PM/dermatomyositis (DM) or antisynthetase syndrome following anti-TNF therapy is extremely rare. Here, we report a case of an RA patient with anti-PL-12 antibodies, who received ETN therapy and subsequently developed the antisynthetase syndrome. She recovered when ETN therapy was withdrawn and high-dose corticosteroid was administered. To date, there have been only five reported cases of RA patients with anti-Jo-1 antibodies who developed overt PM/DM following anti-TNF therapy and only one case of antisynthetase syndrome in an RA patient with anti-PL-7 antibodies. Our patients and the abovementioned reports strongly suggest that onset of overt PM/DM or antisynthetase syndrome in RA patients with anti-aminoacyl tRNA synthetase antibodies is associated with anti-TNF therapy.</div></front></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Ishikawa, Yuki" sort="Ishikawa, Yuki" uniqKey="Ishikawa Y" first="Yuki" last="Ishikawa">Yuki Ishikawa</name></noRegion><name sortKey="Fujii, Takao" sort="Fujii, Takao" uniqKey="Fujii T" first="Takao" last="Fujii">Takao Fujii</name><name sortKey="Kawabata, Daisuke" sort="Kawabata, Daisuke" uniqKey="Kawabata D" first="Daisuke" last="Kawabata">Daisuke Kawabata</name><name sortKey="Mimori, Tsuneyo" sort="Mimori, Tsuneyo" uniqKey="Mimori T" first="Tsuneyo" last="Mimori">Tsuneyo Mimori</name><name sortKey="Ohmura, Koichiro" sort="Ohmura, Koichiro" uniqKey="Ohmura K" first="Koichiro" last="Ohmura">Koichiro Ohmura</name><name sortKey="Usui, Takashi" sort="Usui, Takashi" uniqKey="Usui T" first="Takashi" last="Usui">Takashi Usui</name><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name><name sortKey="Yukawa, Naoichiro" sort="Yukawa, Naoichiro" uniqKey="Yukawa N" first="Naoichiro" last="Yukawa">Naoichiro Yukawa</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001593 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001593 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:5A9AABB4733C827458F8010779A757CB34A27F0F
|texte= A case of antisynthetase syndrome in a rheumatoid arthritis patient with anti-PL-12 antibody following treatment with etanercept
}}
| This area was generated with Dilib version V0.6.33. |  |